Literature DB >> 9256954

Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir.

M A Conant, K M Opp, D Poretz, R G Mills.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256954     DOI: 10.1097/00002030-199710001-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

Review 1.  A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.

Authors:  G Nasti; D Errante; S Santarossa; E Vaccher; U Tirelli
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

Review 2.  Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention.

Authors:  Soren Gantt; Corey Casper; Richard F Ambinder
Journal:  Curr Opin Oncol       Date:  2013-09       Impact factor: 3.645

3.  Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

Authors:  Michael J Silverberg; Donald I Abrams
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

4.  Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.

Authors:  Soren Gantt; Ashok Cattamanchi; Elizabeth Krantz; Amalia Magaret; Stacy Selke; Steven R Kuntz; Meei-Li Huang; Lawrence Corey; Anna Wald; Corey Casper
Journal:  J Clin Virol       Date:  2014-03-13       Impact factor: 3.168

Review 5.  The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process.

Authors:  Giovanni Barillari
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

Review 6.  The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs.

Authors:  Giovanni Barillari
Journal:  Front Oncol       Date:  2020-05-21       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.